why choose us

First received: July 25, 2025

Clinical Trial: Cervical Cancer Screening Via Self-sampling

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Cervical Cancer Screening

Study Type: INTERVENTIONAL


Official Title: Cervical Cancer Screening Using Self-sampling Approach: Validation of Human Papillomavirus Self-sampling Kits Among Kazakhstani Women

Brief Summary: Prevention of cervical cancer is one of the priority areas of the Comprehensive Plan to Combat Cancer in the Republic of Kazakhstan for 2023-2027. High-risk human papillomavirus (HR-HPV) infections cause a wide variety of benign and malignant conditions, including cervical cancer. More than 90% of cervical cancer cases are attributed to HR-HPV infections, with HPV-16 and HPV-18 being reported to cause 70-75% of cases. At the present time, cervical cancer remains the fourth most prevalent cancer among women…

Read more